Pharma Marketing News is the monthly newsletter of the Pharma Marketing Network. It is distributed FREE to registered subscribers via email and the Web.
Editorial & Advisory Board
We accept advertising relevant to the interests of our subscribers.
For more information, see:
Published by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
Subscribe | Newsletter | Forum | Resources | Vendor Directory | Meetings | Jobs
Home | Advertising Information | FAQs | About Us
Vol. 1, No. 9: November 2002
SUMMARY
Although most experts agree that pharmaceutical companies are not covered entities under HIPAA, this does not mean that pharma marketers should not worry about it. Pharma needs to realize that HIPAA will have a significant impact on the commercial side of their business. One effect, for example, will be HIPAA's influence on state medical privacy laws, which may directly affect pharmaceutical companies and their advertising and marketing partners (see article "Texas Medical Privacy Act: A Wolf in Sheep's Clothing?" in this issue),
This article is a summary of a presentation by Brent Saunders, Partner, PricewaterhouseCoopers. The presentation was made at the Pharmaceutical Regulatory & Compliance Congress and Best Practices Forum held at the Philadelphia Marriott Hotel on November 13-15, 2002.
Full Text Version
Read the full text of this article (includes charts; PDF format).